Ad
LGND Short Information Ligand Pharmaceuticals Incorporated
home / stock / lgnd / lgnd short
Short Information | Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 522,433 |
| Total Actual Volume | 2,558,384 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 26,122 |
| Average Short Percentage | 19.58% |
Is there a LGND Short Squeeze or Breakout about to happen?
See the LGND Short Analysis for free Sign up or Login
Powered by Squeeze Report
LGND Twenty Trading Day's Volume to Short Volume Chart
LGND Twenty Trading Day Price Chart
LGND Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 12-06-2024 | $124.11 | $124.83 | $127.86 | $122.885 | 121,260 | 22,955 | 18.93% |
| 12-05-2024 | $120.08 | $123.51 | $124.24 | $120.08 | 114,826 | 31,518 | 27.45% |
| 12-04-2024 | $120.01 | $120.98 | $123 | $119.73 | 73,308 | 14,652 | 19.99% |
| 12-03-2024 | $122.61 | $119.93 | $123.32 | $119.5 | 81,235 | 13,736 | 16.91% |
| 12-02-2024 | $121.99 | $122.7 | $124 | $119.18 | 83,356 | 13,405 | 16.08% |
| 11-29-2024 | $123.44 | $121.47 | $124.3388 | $120.01 | 72,061 | 20,018 | 27.78% |
| 11-27-2024 | $123.65 | $122.55 | $125 | $121.06 | 88,943 | 22,461 | 25.25% |
| 11-26-2024 | $120.62 | $124.33 | $124.44 | $119.7789 | 182,785 | 47,575 | 26.03% |
| 11-25-2024 | $119.74 | $120.62 | $122.632 | $119.035 | 153,700 | 21,614 | 14.06% |
| 11-22-2024 | $116.22 | $119.19 | $120 | $116.22 | 93,207 | 15,386 | 16.51% |
| 11-21-2024 | $112.8 | $116.55 | $118.1242 | $112.06 | 83,407 | 11,032 | 13.23% |
| 11-20-2024 | $111.59 | $111.56 | $112 | $109.525 | 133,565 | 14,289 | 10.7% |
| 11-19-2024 | $110.72 | $111.8 | $112.265 | $109.78 | 98,184 | 11,853 | 12.07% |
| 11-18-2024 | $110.87 | $111.67 | $113.04 | $109.44 | 125,916 | 23,231 | 18.45% |
| 11-15-2024 | $116.52 | $111.71 | $116.52 | $110.3244 | 107,763 | 25,189 | 23.37% |
| 11-14-2024 | $123.22 | $115.45 | $125.76 | $114.39 | 135,153 | 25,822 | 19.11% |
| 11-13-2024 | $122 | $122.08 | $123.72 | $120.99 | 219,090 | 40,531 | 18.5% |
| 11-12-2024 | $123.08 | $120.74 | $124.4574 | $119.685 | 120,763 | 12,725 | 10.54% |
| 11-11-2024 | $122.24 | $123.47 | $124.19 | $120.83 | 209,239 | 53,065 | 25.36% |
| 11-08-2024 | $126.27 | $121.25 | $127.26 | $116.96 | 260,623 | 81,376 | 31.22% |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
Ligand Pharmaceuticals Incorporated Website:
Ad
-
2024-11-24 06:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will present at the Stifel 2024 Healthcare Conference in New York on Tuesday, November 19, 2024, at 12:40 p.m. Eastern Time. Management is sched...
-
Third quarter performance driven by strong portfolio royalty revenue growth 2024 full year revenue guidance increased to $160 million - $165 million (previously $140 million - $157 million) and core adjusted earnings per diluted share 1 increased to $5.50 - $5.70 (previously $5.00 - $...